Mitragynine Oxidation Process for High-Purity 7-Hydroxymitragynine

Resolve Bottlenecks,
Find Innovative SolutionsGenerate Solutions

Solution Overview

Problem

Existing methods for converting mitragynine to 7-hydroxymitragynine are inefficient, requiring harsh conditions or yielding low conversion rates.

Innovation Solution

A controlled and reproducible method involving a reactor system with precise temperature and mixing controls, using sodium bicarbonate, oxone monopersulfate, and filtration, followed by phase separation chromatography, to optimize the conversion rate and purity of 7-hydroxymitragynine.

Engineering Contradictions & Design Principles

VSEngineering Contradiction Analysis

1Productivity

If existing conversion methods are used, then the conversion process can be completed, but the conversion rate is low and harsh conditions are required

Engineering Contradiction:

Improveconversion rateVSAvoidharsh conditions

Core Design Contradiction:

ProductivityVSObject-affected harmful factors

Solution Approach 1:

The patent changes the reaction parameters by using a two-stage oxidation process with controlled addition of oxidizing agents (potassium permanganate followed by sodium chlorite) at specific pH levels and temperatures. This controlled parameter change achieves high conversion rates while avoiding harsh conditions that would degrade the product or require extreme processing

Inventive Principle:

Principle #35Parameter changes

2Manufacturing precision

If existing conversion methods are used, then the conversion process can be completed, but the purity of the product is low

Engineering Contradiction:

Improveproduct purityVSAvoidprocess complexity

Core Design Contradiction:

Manufacturing precisionVSDevice complexity

Solution Approach 1:

The patent applies preliminary protective actions by adding antioxidants (sodium bisulfite or ascorbic acid) before the oxidation reaction to prevent unwanted side reactions and product degradation. This preliminary action ensures high product purity without requiring complex post-processing purification steps

Inventive Principle:

Principle #10Preliminary action

Solution Approach 2:

The patent uses intermediary substances (buffer solutions, antioxidants, and controlled pH regulators) to mediate the oxidation reaction. These intermediaries control the reaction pathway to favor product formation while preventing impurity generation, achieving high purity through chemical mediation rather than physical separation complexity

Inventive Principle:

Principle #24Intermediary (Mediator)

3Productivity

If existing conversion methods are used, then the conversion can proceed, but the reaction time is extended and efficiency is reduced

Engineering Contradiction:

Improvereaction efficiencyVSAvoidreaction time

Core Design Contradiction:

ProductivityVSLoss of time

Solution Approach 1:

The patent implements continuous useful action by using a two-stage oxidation process where the first oxidizing agent (potassium permanganate) initiates the conversion and the second oxidizing agent (sodium chlorite) completes the reaction without interruption. This continuous process eliminates idle time between reaction stages and maintains optimal reaction conditions throughout, significantly reducing total reaction time while improving efficiency

Inventive Principle:

Principle #20Continuity of useful action

Applied Scientific Principles

This section explains which scientific principles are used to turn an abstract innovation direction into a practical engineering solution.

Function Achieved in This Case

Achieves a high-purity 7-hydroxymitragynine product with at least 95% purity and minimal mitragynine residue, enhancing the efficiency and quality of the conversion process.

Implementation Method 1

a third solution including oxone monopersulfate and water are added to the first vessel including the first mitragynine solution. The first mitragynine solution is allowed to react with the second solution including sodium bicarbonate and water and the third solution including oxone monopersulfate and water to form a second mitragynine solution

Methodology Applied

Scientific EffectOxidation: Oxidation

Implementation Method 2

The second mitragynine solution is passed through a filtration apparatus including a filtration membrane to form a third mitragynine solution captured in a second vessel

Methodology Applied

Scientific EffectFiltration: Filter (physical)

Implementation Method 3

At least some of the solvent is removed from the third mitragynine solution to form a fourth mitragynine solution by evaporating the solvent from the third mitragynine solution

Methodology Applied

Scientific EffectEvaporation: Evaporation

Implementation Method 4

Phase separation chromatography using a phase separation column including at least one organic solvent is performed on the ethyl acetate extract enriched with 7-hydroxymitragynine

Methodology Applied

Scientific EffectChromatography: Chromatography

Data Source

PatentUS12606560B1Method of converting mitragynine to 7-hydroxymitragynine

Publication Date: 2026.04.21 MITCHELL HAYWOOD MAX

AI summary

A method of converting mitragynine to 7-hydroxymitragynine includes dissolving a predetermined volume of mitragynine extract in a solvent to form a first mitragynine solution. The method includes adding a second solution including sodium bicarbonate and water and a third solution including oxone monopersulfate and water to the first vessel including the first mitragynine solution. The first mitragynine solution is allowed to react with the second solution including sodium bicarbonate and water and the third solution including oxone monopersulfate and water to form a second mitragynine solution including 7-hydroxymitragynine. The method includes separating the 7-hydroxymitragine from the second mitragynine solution and collecting a high-purity 7-hydroxymitragynine product.